Literature DB >> 3920877

Chronic seizure disorders: contribution of MR imaging when CT is normal.

D W Laster, J K Penry, D M Moody, M R Ball, R L Witcofski, A R Riela.   

Abstract

One hundred consecutive patients with complex partial seizures were studied by magnetic resonance (MR) imaging and computed tomography (CT). Thirty-four patients had seizures of more than 5 years' duration, yet neurologic examinations and previous pre- and postinfusion CT scans had been normal. MR imaging demonstrated surgical lesions of potentially therapeutic significance in four of these 34 patients. Two patients underwent surgery with removal of a thrombosed arteriovenous malformation and a glioma. Although CT has been found to detect structural abnormalities, its yield of therapeutically significant abnormalities has been low.

Entities:  

Mesh:

Year:  1985        PMID: 3920877      PMCID: PMC8332875     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  4 in total

1.  Brain SPECT imaging in temporal lobe epilepsy.

Authors:  Y Krausz; D Cohen; S Konstantini; Z Meiner; S Yaffe; H Atlan
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 2.  Magnetic resonance imaging of the brain and spine.

Authors:  D M Hadley; G M Teasdale
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

3.  Limited value of interictal brain perfusion SPECT for detection of epileptic foci: high resolution SPECT studies in comparison with FDG-PET.

Authors:  T Nagata; F Tanaka; Y Yonekura; A Ikeda; S Nishizawa; K Ishizu; H Okazawa; K Terada; N Mikuni; I Yamamoto
Journal:  Ann Nucl Med       Date:  1995-05       Impact factor: 2.668

4.  Magnetic resonance imaging in the management of resistant focal epilepsy: pathological case report and experience of 12 cases.

Authors:  R Grant; D M Hadley; B Condon; D Doyle; J Patterson; I Bone; S L Galbraith; G M Teasdale
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.